BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31050087)

  • 1. Functional classification of ATM variants in ataxia-telangiectasia patients.
    Fiévet A; Bellanger D; Rieunier G; Dubois d'Enghien C; Sophie J; Calvas P; Carriere JP; Anheim M; Castrioto A; Flabeau O; Degos B; Ewenczyk C; Mahlaoui N; Touzot F; Suarez F; Hully M; Roubertie A; Aladjidi N; Tison F; Antoine-Poirel H; Dahan K; Doummar D; Nougues MC; Ioos C; Rougeot C; Masurel A; Bourjault C; Ginglinger E; Prieur F; Siri A; Bordigoni P; Nguyen K; Philippe N; Bellesme C; Demeocq F; Altuzarra C; Mathieu-Dramard M; Couderc F; Dörk T; Auger N; Parfait B; Abidallah K; Moncoutier V; Collet A; Stoppa-Lyonnet D; Stern MH
    Hum Mutat; 2019 Oct; 40(10):1713-1730. PubMed ID: 31050087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three new cases of ataxia-telangiectasia-like disorder: No impairment of the ATM pathway, but S-phase checkpoint defect.
    Fiévet A; Bellanger D; Valence S; Mobuchon L; Afenjar A; Giuliano F; Dubois d'Enghien C; Parfait B; Pedespan JM; Auger N; Rieunier G; Collet A; Burglen L; Stoppa-Lyonnet D; Stern MH
    Hum Mutat; 2019 Oct; 40(10):1690-1699. PubMed ID: 31033087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel variants in the ATM gene causing ataxia-telangiectasia, including a duplication of 90 kb: Utility of targeted next-generation sequencing in detection of copy number variation.
    Martin-Rodriguez S; Calvo-Ferrer A; Ortega-Unanue N; Samaniego-Jimenez L; Sanz-Izquierdo MP; Bernardo-Gonzalez I
    Ann Hum Genet; 2019 Jul; 83(4):266-273. PubMed ID: 30888062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of pathogenicity for the leaky splice variant c.1066-6T>G in ATM.
    Schröder S; Wieland B; Ohlenbusch A; Yigit G; Altmüller J; Boltshauser E; Dörk T; Brockmann K
    Am J Med Genet A; 2020 Dec; 182(12):2971-2975. PubMed ID: 32918381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype correlations in ataxia telangiectasia patients with
    van Os NJH; Chessa L; Weemaes CMR; van Deuren M; Fiévet A; van Gaalen J; Mahlaoui N; Roeleveld N; Schrader C; Schindler D; Taylor AMR; Van de Warrenburg BPC; Dörk T; Willemsen MAAP
    J Med Genet; 2019 May; 56(5):308-316. PubMed ID: 30819809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype relationships in ataxia-telangiectasia and variants.
    Gilad S; Chessa L; Khosravi R; Russell P; Galanty Y; Piane M; Gatti RA; Jorgensen TJ; Shiloh Y; Bar-Shira A
    Am J Hum Genet; 1998 Mar; 62(3):551-61. PubMed ID: 9497252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
    Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.
    Jacquemin V; Rieunier G; Jacob S; Bellanger D; d'Enghien CD; Laugé A; Stoppa-Lyonnet D; Stern MH
    Eur J Hum Genet; 2012 Mar; 20(3):305-12. PubMed ID: 22071889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis.
    Tabatabaiefar MA; Alipour P; Pourahmadiyan A; Fattahi N; Shariati L; Golchin N; Mohammadi-Asl J
    J Neurol Sci; 2017 Aug; 379():212-216. PubMed ID: 28716242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia-telangiectasia: A review of clinical features and molecular pathology.
    Amirifar P; Ranjouri MR; Yazdani R; Abolhassani H; Aghamohammadi A
    Pediatr Allergy Immunol; 2019 May; 30(3):277-288. PubMed ID: 30685876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.
    Mitui M; Nahas SA; Du LT; Yang Z; Lai CH; Nakamura K; Arroyo S; Scott S; Purayidom A; Concannon P; Lavin M; Gatti RA
    Hum Mutat; 2009 Jan; 30(1):12-21. PubMed ID: 18634022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of ATM gene mutations in 66 ataxia telangiectasia families.
    Sandoval N; Platzer M; Rosenthal A; Dörk T; Bendix R; Skawran B; Stuhrmann M; Wegner RD; Sperling K; Banin S; Shiloh Y; Baumer A; Bernthaler U; Sennefelder H; Brohm M; Weber BH; Schindler D
    Hum Mol Genet; 1999 Jan; 8(1):69-79. PubMed ID: 9887333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Granulomatosis and Class Switching Defect as a Presenting Sign in Ataxia-Telangiectasia: First Case from the National Iranian Registry and Review of the Literature.
    Amirifar P; Yazdani R; Moeini Shad T; Ghanadan A; Abolhassani H; Lavin M; Sotoudeh S; Aghamohammadi A
    Immunol Invest; 2020 Aug; 49(6):597-610. PubMed ID: 31762358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms.
    Blanchard-Rohner G; Peirolo A; Coulon L; Korff C; Horvath J; Burkhard PR; Gumy-Pause F; Ranza E; Jandus P; Dibra H; Taylor AMR; Fluss J
    Front Immunol; 2022; 13():791522. PubMed ID: 35154108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease.
    Ricci A; Biancucci F; Morganti G; Magnani M; Menotta M
    Cell Mol Life Sci; 2022 Nov; 79(12):601. PubMed ID: 36422718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia.
    Worth PF; Srinivasan V; Smith A; Last JI; Wootton LL; Biggs PM; Davies NP; Carney EF; Byrd PJ; Taylor AM
    Mov Disord; 2013 Apr; 28(4):524-8. PubMed ID: 23143971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-Telangiectasia.
    Carranza D; Vega AK; Torres-Rusillo S; Montero E; Martinez LJ; Santamaría M; Santos JL; Molina IJ
    Neuromolecular Med; 2017 Mar; 19(1):161-174. PubMed ID: 27664052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia telangiectasia syndrome: moonlighting ATM.
    Zaki-Dizaji M; Akrami SM; Abolhassani H; Rezaei N; Aghamohammadi A
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1155-1172. PubMed ID: 29034753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone partially rescues ataxia telangiectasia-mutated (ATM) deficiency in ataxia telangiectasia by promoting a shortened protein variant retaining kinase activity.
    Menotta M; Biagiotti S; Bianchi M; Chessa L; Magnani M
    J Biol Chem; 2012 Nov; 287(49):41352-63. PubMed ID: 23055520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic Analysis of ATM Protein Kinase in DNA Double-Strand Break Formation and Repair.
    Mian E; Wiesmüller L
    Methods Mol Biol; 2017; 1599():317-334. PubMed ID: 28477129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.